Yahoo
HKSE - Delayed Quote HKD

CPBIO Holding Company Limited (3839.HK)

7.795 +0.015 (+0.19%)
As of 10:34:08 AM GMT+8. Market Open.
Chart Range Bar
Loading chart for 3839.HK
  • Previous Close 7.780
  • Open 7.780
  • Bid 7.690 x --
  • Ask 7.795 x --
  • Day's Range 7.770 - 7.800
  • 52 Week Range 5.500 - 9.890
  • Volume 217,500
  • Avg. Volume 41,133
  • Market Cap (intraday) 1.876B
  • Beta (5Y Monthly) 4.06
  • PE Ratio (TTM) 10.26
  • EPS (TTM) 0.760
  • Earnings Date (est.) --
  • Forward Dividend & Yield -- (0.00%)
  • Ex-Dividend Date --
  • 1y Target Est --

CPBIO Holding Company Limited manufactures and sells animal health products and chlortetracycline in Mainland China, the Asia Pacific, the Americas, Europe, and internationally. It operates through two segments: Biotech Business and Investment Business. The Biochemical segment is engaged in the manufacture and/or sale of animal health products and chlortetracycline, which are used as feed additives to promote growth of livestock, prevent or cure animal diseases, and enhance efficiency under the Shihao and Citifac brand names. The company offers products such as gut & health enhancement, antibioticsanticoc & antiparasitics, bioprotection, detection kits, enzyme, plant extracts, vaccine, and trade. The company also provides solution for poultry, swine, ruminants, and aquaculture. The Investment segment is engaged in the trading of machinery and the manufacture and sale of automotive parts; and caterpillar products, including excavators, power generators, bulldozers and compactors, as well as spare parts; and the manufacture and sale of motorcycle carburetors. The company serves livestock farms, pharmaceutical companies, trading companies, feed mills, automobile manufacturers, and motorcycle manufacturers. CPBIO Holding Company Limited was formerly known as Chia Tai Enterprises International Limited and changed its name to CPBIO Holding Company Limited in July 2026. CPBIO Holding Company Limited was incorporated in 1987 and is based in Central, Hong Kong.

www.cp-bio.com

1,000

Full Time Employees

December 31

Fiscal Year Ends

Healthcare

Sector

Recent News

View More

Performance Overview

Trailing total returns as of 11/5/2026, which may include dividends or other distributions. Benchmark is HANG SENG INDEX (^HSI) .

YTD Return

3839.HK
7.37%
HANG SENG INDEX (^HSI)
3.53%

1-Year Return

3839.HK
14.30%
HANG SENG INDEX (^HSI)
4.67%

3-Year Return

3839.HK
533.74%
HANG SENG INDEX (^HSI)
39.97%

5-Year Return

3839.HK
441.32%
HANG SENG INDEX (^HSI)
0.58%

Statistics

View More

Valuation Measures

Annual
  • Market Cap

  • Enterprise Value

  • Trailing P/E

  • Forward P/E

  • PEG Ratio (current)

  • Price/Sales (ttm)

  • Price/Book (mrq)

  • Enterprise Value/Revenue

  • Enterprise Value/EBITDA

Financial Highlights

Profitability and Income Statement

  • Profit Margin

    5.76%

  • Return on Assets (ttm)

    3.93%

  • Return on Equity (ttm)

    8.87%

  • Revenue (ttm)

    423.98M

  • Net Income Avi to Common (ttm)

    24.43M

  • Diluted EPS (ttm)

    0.760

Balance Sheet and Cash Flow

  • Total Cash (mrq)

    37.25M

  • Total Debt/Equity (mrq)

    23.16%

  • Levered Free Cash Flow (ttm)

    -20.03M

Company Insights

Research Reports

View More

People Also Watch

Mobilize your Website
View Site in Mobile | Classic
Share by: